$21.30

FREE
SHIPPING

100% MONEY
BACK GUARANTEE

ONLINE
SUPPORT 24/7

Available on backorder. No lead time available. Please request a quote.
Sku CI02631_5_G
Chem Impex
Get Bulk Quote

Product Information

Product Name
Acetyl-L-proline
Brand Name
Chem Impex
Product Number
02631
CAS
68-95-1
Certificate of Analysis (COA)​
COA not found

General Information

PubChem CID
66141
IUPAC Name
(2S)-1-acetylpyrrolidine-2-carboxylic acid
InChI Key
GNMSLDIYJOSUSW-LURJTMIESA-N
SMILES
CC(=O)N1CCCC@H1C(=O)O

Application

Acetyl-L-proline is widely utilized in research focused on

Pharmaceutical Development: It serves as a building block in the synthesis of various pharmaceuticals, particularly in the development of drugs targeting neurological disorders.

Peptide Synthesis: This compound is crucial in peptide synthesis, enhancing the stability and bioactivity of peptides used in therapeutic applications.

Cosmetic Formulations: Acetyl-L-proline is incorporated into skin care products for its moisturizing properties, helping to improve skin texture and hydration.

Food Industry: It acts as a flavor enhancer and stabilizer in food products, contributing to improved taste and shelf life.

Research in Biochemistry: The compound is used in biochemical studies to understand protein folding and enzyme activity, providing insights into cellular processes.

References Data Source From Pubchem

Fragment Screening and Structure-Guided Development of Heparanase Inhibitors Reveal Orthosteric and Allosteric Inhibition

Publication Name: ACS Medicinal Chemistry Letters
Publication Date: 2026-02-03
DOI: 10.1021/acsmedchemlett.5c00587

High-throughput LDI MS technology decodes the distinct metabolic landscape of prostate cancer in a large-scale cohort

Publication Name: Biomarker Research
Publication Date: 2025-07-09
DOI: 10.1186/s40364-025-00804-z

Metabolomic alterations in human brain microvascular endothelial cells induced by traumatic injury

Publication Name: Metabolomics : Official journal of the Metabolomic Society
Publication Date: 2025-06-27
DOI: 10.1007/s11306-025-02286-4